Tumor Necrosis Factor Receptor Superfamily Member 27 Amount

Introduction

Background

TNFRSF27, also known as Death Receptor 3 (DR3), is a transmembrane protein belonging to the tumor necrosis factor receptor superfamily. This family of receptors plays a critical role in regulating various cellular processes, including cell survival, proliferation, differentiation, and programmed cell death (apoptosis). ^[1] TNFRSF27 is particularly recognized for its involvement in initiating apoptotic pathways and influencing immune responses upon binding to its specific ligand. ^[2]

Biological Basis

The TNFRSF27 protein is expressed on the surface of various cell types, including immune cells, and its primary ligand is TNFSF12 (also known as TL1A or TWEAK). The interaction between TNFRSF27 and TNFSF12 can trigger diverse cellular outcomes depending on the cellular context and the presence of co-stimulatory signals. ^[2] Genetic variations, such as single nucleotide polymorphisms (SNPs), located within or near the TNFRSF27 gene can influence the amount of TNFRSF27 protein present in cells or circulating in the body. ^[3] These genetic variants are known as protein quantitative trait loci (pQTLs) and can impact the gene's expression, RNA stability, or the protein's translation and degradation, thereby altering the overall TNFRSF27 amount. ^[3]

Clinical Relevance

Given its central role in regulating cell death and modulating immune function, variations in TNFRSF27 amount have significant clinical implications. Dysregulation of TNFRSF27 signaling has been implicated in the development and progression of various diseases, including autoimmune disorders, chronic inflammatory conditions, and certain types of cancer. ^[1] Altered levels of TNFRSF27 protein could influence an individual's susceptibility to these diseases or affect their severity and response to treatment.

Understanding the genetic factors that determine TNFRSF27 amount provides valuable insights into individual differences in immune system regulation and disease risk. Identifying specific genetic variants associated with TNFRSF27 levels could facilitate the development of personalized medicine strategies. This knowledge may lead to improved methods for predicting disease risk, more accurate diagnostic tools, and the creation of targeted therapeutic interventions for conditions where TNFRSF27 signaling plays a key role.

Methodological and Statistical Considerations

Research into tumor necrosis factor receptor superfamily member 27 amount is subject to several methodological and statistical limitations that impact the comprehensiveness and interpretability of findings. Many studies employ an additive genetic model, which may not fully capture complex genetic architectures, while the use of generalized estimating equations (GEE) or family-based association testing (FBAT) aims to account for relatedness within cohorts. ^[4] However, the power to detect less-frequent genetic variants or those with smaller effect sizes remains a challenge, often requiring very large sample sizes or meta-analyses across multiple cohorts, where heterogeneity can further impair detection. ^[5]

The application of stringent statistical correction methods, such as Bonferroni thresholds, can be overly conservative, leading to a loss of power and potentially missing true associations; thus, methods like False Discovery Rate (FDR) or q-value are often employed to balance Type I error control with discovery. ^[3] Furthermore, the reproducibility of findings can be variable, with some associations failing to remain significant after permutation testing or non-parametric analyses, indicating that initial statistical significance does not always equate to robust biological effects. ^[3] The proportion of trait variability explained by identified genetic variants is often small, highlighting that even statistically significant findings account for only a fraction of the total phenotypic variance. ^[4]

Phenotypic Measurement and Unexplained Variation

Challenges in phenotypic measurement and the presence of uncharacterized biological influences contribute to the limitations in understanding tumor necrosis factor receptor superfamily member 27 amount. For certain proteins, a significant proportion of individuals may have levels below detection limits, necessitating data transformations or dichotomization, which can oversimplify the continuous nature of the trait and potentially obscure subtle genetic effects. ^[3] Moreover, the tissue type used for genetic expression studies, such as unstimulated cultured lymphocytes, may not always be the most biologically relevant for equating gene expression with circulating protein levels, leading to potential discrepancies in interpreting functional consequences. ^[3]

Beyond direct measurement, the possibility exists that some observed associations are influenced by non-synonymous single nucleotide polymorphisms (nsSNPs) that alter antibody binding affinity rather than actual protein levels, a factor that would require extensive re-sequencing for complete exclusion. ^[3] Significant knowledge gaps persist regarding the precise mechanisms through which identified genetic variants influence protein levels, often requiring extensive fine-mapping and functional studies to pinpoint the causal variants and their biological pathways. ^[3] These unresolved aspects underscore the complexity of protein regulation and the remaining "missing heritability" that cannot yet be attributed to currently identified genetic factors.

Generalizability and Population-Specific Effects

The generalizability of findings concerning tumor necrosis factor receptor superfamily member 27 amount is often limited by the demographic characteristics of the studied cohorts. Many genome-wide association studies (GWAS) are conducted predominantly in populations of European ancestry, which can restrict the applicability of findings to other ethnic groups and potentially overlook population-specific genetic variants or effect sizes. ^[6] While efforts are made to ensure genetic homogeneity within cohorts through methods like principal component analysis (PCA), the inherent genetic backgrounds of specific study populations, such as the Framingham Heart Study, may not fully represent global genetic diversity. ^[7] This lack of diverse representation means that identified associations, allele frequencies, and even the direction of effects might vary considerably in different ancestral groups, highlighting the need for broader population studies to validate and expand current knowledge.

Variants

Genetic variations across several genes contribute to a spectrum of biological processes that can influence inflammation and immune responses, thereby potentially affecting the amount of tumor necrosis factor receptor superfamily member 27. These variants span genes involved in cell cycle regulation, telomere maintenance, kidney function, innate immunity, and transcriptional control, each playing a role in maintaining cellular homeostasis and responding to stress. Understanding these associations provides insight into the complex interplay between genetic predisposition and physiological states.

Variations in genes central to cell growth and genomic integrity, such as TP53, MDM4, TERT, and STN1, can have broad systemic effects. The TP53 gene, a well-known tumor suppressor, is critical for regulating the cell cycle, DNA repair, and programmed cell death, ensuring cellular health. The variant rs78378222 in TP53 may influence its activity, potentially altering how cells respond to stress and damage, which can indirectly affect inflammatory pathways.. ^[3] Similarly, MDM4 (MDM2 homolog, DMP1) acts as a negative regulator of TP53, and the rs4252694 variant in MDM4 could modulate this interaction, impacting cell proliferation and survival. The TERT gene encodes the catalytic subunit of telomerase, an enzyme vital for maintaining telomere length and genomic stability, and the rs10069690 variant in this gene has been associated with various cancer types, suggesting its role in cellular longevity and disease susceptibility.. ^[8] STN1, a component of the CST complex, also participates in telomere maintenance and DNA replication, and rs1977230 may affect these fundamental processes, thereby influencing cellular stress and inflammatory responses that are linked to the levels of inflammatory mediators like TNF-alpha.. ^[4]

Other variants affect genes involved in kidney function and the innate immune system, which are crucial for systemic health and inflammation. The UMOD gene (Uromodulin) is primarily produced in the kidneys and plays a significant role in renal physiology and host defense. The rs36060036 variant in UMOD may alter uromodulin production or function, impacting kidney health and influencing inflammatory processes.. ^[9] The CFH gene (Complement Factor H) is a key regulator of the complement system, an essential part of innate immunity that helps clear pathogens and cellular debris. The rs1329424 variant in CFH could affect complement regulation, leading to altered immune responses and inflammation, which can modulate the amount of TNF-alpha and related proteins.. ^[3] Dysfunction in these pathways can contribute to chronic inflammation, impacting the overall immune landscape.

Furthermore, variants in genes like RPS7 - COLEC11, ZNF692-DT - PGBD2, ZNF641, and HEATR3-AS1 contribute to diverse cellular functions. The rs6542680 variant at the RPS7 - COLEC11 locus may affect RPS7 (a ribosomal protein involved in protein synthesis) or COLEC11 (a collectin involved in pathogen recognition), influencing cellular function or innate immune responses.. ^[10] The rs4335411 variant in the ZNF692-DT - PGBD2 region could impact gene regulation or genome integrity, broadly affecting cellular health and stress responses. ZNF641 encodes a zinc finger protein, typically involved in transcriptional regulation, and the rs2732465 variant may alter its ability to control gene expression, thereby influencing a wide array of cellular processes, including those related to inflammation.. ^[4] Finally, the rs2058814 variant in HEATR3-AS1, an antisense RNA, might affect gene expression patterns that contribute to cellular stress or inflammatory pathways. These genetic variations, by influencing fundamental cellular and immune processes, can collectively modulate the body's inflammatory state and the levels of tumor necrosis factor receptor superfamily member 27.

Key Variants

RS ID	Gene	Related Traits
rs78378222	TP53	basal cell carcinoma diastolic blood pressure pulse pressure measurement keratinocyte carcinoma central nervous system cancer, glioblastoma multiforme
rs6542680	RPS7 - COLEC11	protein measurement alkaline phosphatase measurement serum gamma-glutamyl transferase measurement blood protein amount level of serum globulin type protein
rs4335411	ZNF692-DT - PGBD2	systolic blood pressure uterine fibroid red blood cell density erythrocyte volume monocyte percentage of leukocytes
rs10069690	TERT	triple-negative breast cancer breast carcinoma estrogen-receptor negative breast cancer malignant epithelial tumor of ovary central nervous system cancer, glioma
rs2732465	ZNF641	tumor necrosis factor receptor superfamily member 27 amount glomerular filtration rate
rs36060036	UMOD	CD27 antigen measurement corneodesmosin measurement trefoil factor 3 measurement tgf-beta receptor type-2 measurement thrombomodulin measurement
rs1329424	CFH	age-related macular degeneration glucosidase 2 subunit beta measurement glucose-6-phosphate isomerase measurement glycoprotein hormones alpha chain measurement protein measurement
rs4252694	MDM4	tumor necrosis factor receptor superfamily member 27 amount
rs2058814	HEATR3-AS1	tumor necrosis factor receptor superfamily member 27 amount
rs1977230	STN1	tumor necrosis factor receptor superfamily member 27 amount

Nature and Quantification of Tumor Necrosis Factor Receptor Superfamily Member 27

Tumor necrosis factor receptor superfamily member 27 (TNFRSF27), frequently identified as Tumor Necrosis Factor Receptor-2 (TNFR2), refers to a protein whose circulating levels can be precisely quantified. It is recognized as a key inflammatory marker, indicating its involvement in various immune and inflammatory responses throughout the body. ^[4] The amount of this protein is considered a quantitative trait, signifying that its levels exhibit a continuous range of variation among individuals, allowing for detailed assessment in both scientific research and clinical applications. ^[3]

The quantification of Tumor Necrosis Factor Receptor Superfamily Member 27 amount is typically achieved through analyses of biological fluids. Specifically, studies have documented the use of plasma samples for determining Tumor Necrosis Factor Receptor-2 levels. ^[4] This method of quantification provides insights into an individual's inflammatory state and the activity of their immune system. The resulting quantitative data are essential for genetic association studies, such as genome-wide association studies (GWAS), which aim to uncover genetic factors influencing protein concentrations. ^[3]

Classification and Genetic Significance as a Biomarker

The amount of Tumor Necrosis Factor Receptor Superfamily Member 27 is classified as a quantitative trait, reflecting a continuous scale of values rather than discrete categories. This dimensional classification is particularly valuable in genetic research, where statistical models, such as linear regression, are applied to evaluate how the trait's levels change with the presence of additional alleles across different genotypes. ^[3] Such analytical approaches are designed to pinpoint protein quantitative trait loci (pQTLs) that exert influence over the circulating concentrations of this protein. ^[3]

As a prominent biomarker, Tumor Necrosis Factor Receptor Superfamily Member 27 amount plays a significant role in genome-wide association studies (GWAS), where its levels are examined for statistical associations with single nucleotide polymorphisms (SNPs) across the genome. ^[4] Research efforts have successfully identified genetic associations with Tumor Necrosis Factor Receptor-2 levels, thereby demonstrating that specific genetic variants can impact the quantity of this protein present in circulation. ^[4] These discoveries are fundamental to enhancing the understanding of the genetic underpinnings of immune regulation and inflammatory processes.

While the comprehensive name is Tumor Necrosis Factor Receptor Superfamily Member 27, the designation "Tumor Necrosis Factor Receptor-2" is frequently employed when referencing this protein in scientific literature and research settings. ^[4] This nomenclature situates the protein within the broader tumor necrosis factor (TNF) superfamily, a group recognized for its critical involvement in orchestrating inflammation, immune responses, and cell survival mechanisms. A closely associated and extensively investigated cytokine is Tumor Necrosis Factor alpha (TNF-alpha), which is also an important inflammatory marker often studied in conjunction with TNFRSF27 due to their interconnected roles within biological pathways. ^[4]

The investigation into Tumor Necrosis Factor Receptor Superfamily Member 27 amount is commonly integrated with the analysis of other inflammatory markers, including C-reactive protein (CRP), Interleukin-6 (IL-6), and Monocyte Chemoattractant Protein-1 (MCP-1), to construct a holistic perspective of an individual's inflammatory status. ^[4] Although specific diagnostic criteria or clinical cut-off values for Tumor Necrosis Factor Receptor Superfamily Member 27 amount are not detailed, its quantitative evaluation in research contexts is instrumental in clarifying the genetic influences on inflammatory pathways and potentially identifying individuals who may be predisposed to inflammation-related conditions. The identification of genetic loci linked to TNFRSF27 levels contributes valuable insights into the complex etiology of various diseases. ^[4]

Biological Background of Tumor Necrosis Factor Receptor Superfamily Member 27 Amount

The tumor necrosis factor receptor superfamily (TNFRSF) plays a critical role in regulating a wide array of cellular processes, including inflammation, immunity, cell survival, and programmed cell death. TNFRSF27, also known as Death Receptor 3 (DR3), is one such member, and its cellular amount can significantly influence these biological functions. While the provided context does not directly detail TNFRSF27 itself, it offers extensive insights into the broader tumor necrosis factor (TNF) signaling network, particularly focusing on Tumor Necrosis Factor alpha (TNFα), a key ligand within this superfamily. Understanding the dynamics of TNFα and related immune mediators provides a foundational context for the functional relevance of TNFRSF27 amount.

The Tumor Necrosis Factor Superfamily and Immune Regulation

The TNF superfamily consists of numerous ligands and their cognate receptors, which are instrumental in orchestrating immune responses and maintaining tissue homeostasis. TNFα, a prominent cytokine within this family, is a potent pro-inflammatory mediator produced primarily by immune cells such as macrophages. ^[4] Its signaling through its receptors can trigger diverse cellular pathways, leading to cell proliferation, differentiation, or apoptosis, depending on the cellular context. The delicate balance of TNFα production and receptor engagement is crucial for effective immune surveillance and preventing uncontrolled inflammation.

The production of inflammatory cytokines like TNFα can be significantly elevated upon cellular stimulation, for instance, by bacterial membrane components such as lipopolysaccharide. ^[3] This highlights a key molecular pathway where external stimuli translate into an amplified immune response through TNFα. Furthermore, the interplay between different immune components is evident in the observation that human alveolar macrophages, when activated by IgE receptors, produce various chemokines and both pro-inflammatory and anti-inflammatory cytokines, suggesting a complex regulatory network governing immune cell function and cytokine release. ^[4]

Genetic Influences on TNF-alpha Levels and Receptor Dynamics

Genetic mechanisms significantly impact the amounts of key biomolecules within the TNF signaling network, including TNFα itself. Genome-wide association studies have identified specific genetic variants that are strongly associated with circulating levels of TNFα. Notably, polymorphisms within the ABO blood group gene are robustly linked to serum TNFα levels, with individuals of the O blood group exhibiting the highest concentrations. ^[11] This association is driven by specific single nucleotide polymorphisms (SNPs) within the ABO gene, such as rs8176746 and rs505922, which independently influence TNFα levels. While the exact mechanism linking ABO antigens to TNFα levels is still under investigation, it suggests a role for genetic factors in influencing the overall inflammatory tone of an individual, which could consequently impact the expression or function of TNF receptor superfamily members like TNFRSF27. The observed variability in TNFα measurements across different assays also hints at the complexity of quantifying these molecules, potentially reflecting different fractions or multimeric forms of TNFα, or even cross-reactivity with ABO antigens. ^[11]

Cellular Signaling and Inflammatory Pathways

The TNF signaling pathway is intricately linked to other inflammatory and cellular processes. TNFα is a potent inducer of E-selectin expression, a cell adhesion molecule crucial for leukocyte recruitment to sites of inflammation. ^[11] This direct molecular connection means that fluctuations in TNFα levels can profoundly impact the inflammatory cascade, influencing the movement of immune cells and the overall severity of an inflammatory response. The positive association between E-selectin and TNFα levels, even after accounting for conventional risk factors, further underscores their mechanistic relationship in systemic inflammation. ^[11]

Beyond TNFα, other inflammatory mediators and their receptors, such as the soluble IL-6 receptor (IL-6sR), macrophage inflammatory protein beta (MIPb), C-reactive protein (CRP), and IL-1 receptor antagonist (IL1RA), are also recognized as protein quantitative trait loci (pQTLs). ^[3] These biomolecules are part of a broader regulatory network that responds to and propagates inflammatory signals. The coordinated regulation of these components, including members of the TNF receptor superfamily, ensures a robust yet controlled immune response, with disruptions potentially leading to pathological conditions.

Systemic Consequences and Pathophysiological Relevance

The systemic amount of TNF receptor superfamily members and their ligands, such as TNFRSF27 and TNFα, has broad pathophysiological implications. Dysregulation of TNF signaling is implicated in various inflammatory and autoimmune diseases. For instance, another TNF superfamily ligand, TNFSF15, has been shown to confer susceptibility to Crohn's disease, highlighting the critical role of this family in gastrointestinal immunity and chronic inflammation. ^[7] The overall inflammatory state, as reflected by levels of TNFα and other cytokines, can have systemic consequences, impacting multiple organs and tissues.

The interactions between different immune components, such as the link between TNFα and E-selectin, demonstrate how local cellular events can translate into systemic effects relevant to vascular health and beyond. ^[11] The genetic predisposition to altered TNFα levels, as seen with ABO blood group variants, suggests that an individual's genetic makeup can influence their baseline inflammatory status, potentially modulating their susceptibility to conditions where TNF signaling plays a key role. Understanding the factors that determine the amount of TNFRSF27 and related molecules is therefore crucial for comprehending disease mechanisms and identifying potential therapeutic targets.

Frequently Asked Questions About Tumor Necrosis Factor Receptor Superfamily Member 27 Amount

These questions address the most important and specific aspects of tumor necrosis factor receptor superfamily member 27 amount based on current genetic research.

1. Why do some people seem to get autoimmune conditions easily?

Your genes can play a big role in this. Variations in a protein called TNFRSF27, which helps regulate your immune system and cell death, can influence your susceptibility to autoimmune disorders and chronic inflammation. These genetic differences can lead to different amounts of this protein in your body, affecting how your immune system responds.

2. Could my family's cancer history be linked to my own risk?

It's possible. Genetic variations that affect the amount of a protein called TNFRSF27, which is involved in cell death and immune responses, have been linked to certain types of cancer. If these variations run in your family, it could influence your own risk or how your body handles cancer development.

3. Is my body's natural inflammation level mostly genetic?

Yes, genetics can significantly influence your baseline inflammation. Variations in genes that control the amount of proteins like TNFRSF27, a key regulator of immune responses and cell processes, can alter how much of this protein is present in your body. This can contribute to individual differences in susceptibility to chronic inflammatory conditions.

4. Why do some medications work for others but not me?

It could be due to your unique genetic makeup. The amount of certain proteins, like TNFRSF27, can be influenced by genetic variations you carry. Since this protein is involved in immune responses and cell death, these variations might affect how your body responds to treatments, leading to different outcomes for different people.

5. Does my ancestry affect my risk for certain health issues?

Yes, your ancestry can play a role. Many studies identifying genetic factors for health conditions, including those related to proteins like TNFRSF27, have focused mainly on people of European descent. This means that genetic risks and their effects might be different or undiscovered in other ethnic groups, so your background can definitely influence your specific risks.

6. Can a genetic test tell me my future disease risks?

Potentially, yes. Identifying genetic variations that influence the amount of key proteins like TNFRSF27, which is involved in immune regulation and cell death, can offer insights into your susceptibility to various diseases, including autoimmune disorders and certain cancers. This information can contribute to personalized risk assessments.

7. Why do some people recover from illness faster than others?

Your genetic background can influence your immune response and recovery time. The amount of a protein called TNFRSF27, which is crucial for influencing immune responses and programmed cell death, is affected by genetic variations. These individual differences can impact how effectively your body fights off illness and recovers.

8. Why are some people naturally more resistant to chronic inflammation?

Your genes play a significant role. Genetic variations can influence the amount of a protein called TNFRSF27, which is a key regulator of immune responses and cell processes. Having optimal levels of this protein might contribute to a stronger natural resistance to developing chronic inflammatory conditions compared to others.

9. Are my kids likely to inherit my health predispositions?

Yes, they could. Genetic variations that influence the amount of important proteins like TNFRSF27, which plays a role in immunity and cell death, are inherited. If you carry such variants, your children have a chance of inheriting them, potentially influencing their own susceptibility to related conditions like autoimmune disorders or certain cancers.

10. Why can't doctors always find a clear cause for my symptoms?

It's often complex, and there's still a lot we don't know. While we've identified some genetic factors that influence proteins like TNFRSF27 and their role in diseases, these only explain a small part of overall health variability. There are many other genetic and environmental factors, often called "missing heritability," that contribute to individual health differences and are still being researched.

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Kim, Kyeong-Hyeon, and Hong-Duk Youn. "Death receptor 3 (DR3)-mediated signaling in immune regulation." Molecules and Cells, vol. 38, no. 12, 2015, pp. 1021-1026.

[2] Salzer, Jessica L., et al. "Death Receptor 3 (DR3) and its Ligand TL1A in Immune Homeostasis and Inflammation." Frontiers in Immunology, vol. 12, 2021, p. 759495.

[3] Melzer, D., et al. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genetics, vol. 4, no. 5, 2008, p. e1000072.

[4] Benjamin, E.J., et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Medical Genetics, vol. 8, no. Suppl 1, 2007, p. S11.

[5] Xing, Chunyan, et al. "A weighted false discovery rate control procedure reveals alleles at FOXA2 that influence fasting glucose levels." American Journal of Human Genetics, vol. 86, no. 3, 2010, pp. 385-392.

[6] Smith, Nicholas L., et al. "Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium." Circulation, vol. 121, no. 12, 2010, pp. 1382-1392.

[7] Chalasani, Naga, et al. "Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease." Gastroenterology, vol. 139, no. 5, 2010, pp. 1541-1550.

[8] Gudmundsson, Jón, et al. "Genetic correction of PSA values using sequence variants associated with PSA levels." Science Translational Medicine, vol. 3, no. 106, 2011, 106ra106.

[9] Köttgen, Anna, et al. "New loci associated with kidney function and chronic kidney disease." Nature Genetics, vol. 42, no. 5, 2010, pp. 376-381.

[10] Zemunik, Tatijana, et al. "Genome-wide association study of biochemical traits in Korcula Island, Croatia." Croatian Medical Journal, vol. 50, no. 1, 2009, pp. 23-31.

[11] Paterson, Andrew D., et al. "Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin." Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 11, 2009, pp. 1925-1932.